Publications 2024
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial.
Journal of clinical oncology nn, nn (2024) [10.1200/JCO-24-02266]
BibTeX |
EndNote:
XML,
Text |
RIS
Bortezomib before and after high-dose therapy in transplant-eligible patients with newly diagnosed multiple myeloma: Long-term overall survival after more than 10 years of follow-up from the phase III HOVON-65/GMMG-HD4 trial.
HemaSphere 8(11), e70052 (2024) [10.1002/hem3.70052]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.
Neuro-Oncology nn, nn (2024) [10.1093/neuonc/noae238]
BibTeX |
EndNote:
XML,
Text |
RIS
Meningiomas: Sex-Specific Differences and Prognostic Implications of a Chromosome X Loss.
Neuro-Oncology nn, nn (2024) [10.1093/neuonc/noae239]
BibTeX |
EndNote:
XML,
Text |
RIS
Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple Myeloma.
Oncology nn, nn (2024) [10.1159/000541541]
BibTeX |
EndNote:
XML,
Text |
RIS
Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance.
Haematologica nn, nn (2024) [10.3324/haematol.2024.285805]
BibTeX |
EndNote:
XML,
Text |
RIS
Comparing Patient?s Confidence in Clinical Capabilities in Urology: Large Language Models Versus Urologists
European urology open science 70, 91 - 98 (2024) [10.1016/j.euros.2024.10.009]
BibTeX |
EndNote:
XML,
Text |
RIS
STIL overexpression shortens lifespan and reduces tumor formation in mice.
PLoS Genetics 20(10), e1011460 - (2024) [10.1371/journal.pgen.1011460]
BibTeX |
EndNote:
XML,
Text |
RIS
Unleashing the strengths of unlabelled data in deep learning-assisted pan-cancer abdominal organ quantification: the FLARE22 challenge.
The lancet / Digital health 6(11), e815 - e826 (2024) [10.1016/S2589-7500(24)00154-7]
BibTeX |
EndNote:
XML,
Text |
RIS
Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma.
Blood cancer journal 14(1), 176 (2024) [10.1038/s41408-024-01159-8]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma.
Journal for ImmunoTherapy of Cancer 12(10), e009220 (2024) [10.1136/jitc-2024-009220]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Glucocorticoids induce a maladaptive epithelial stress response to aggravate acute kidney injury.
Science translational medicine 16(767), eadk5005 (2024) [10.1126/scitranslmed.adk5005]
BibTeX |
EndNote:
XML,
Text |
RIS
Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma.
Future oncology nn, nn (2024) [10.1080/14796694.2024.2402639]
BibTeX |
EndNote:
XML,
Text |
RIS
Measurable Residual Disease Monitoring in AML With FLT3-ITD Treated With Intensive Chemotherapy Plus Midostaurin.
Blood advances 8(23), 6067-6080 (2024) [10.1182/bloodadvances.2024013758]
BibTeX |
EndNote:
XML,
Text |
RIS
Integration of Transcriptomics, Proteomics and Loss-of-function Screening Reveals WEE1 as a Target for Combination with Dasatinib against Proneural Glioblastoma.
Cancer letters 605, 217265 (2024) [10.1016/j.canlet.2024.217265]
BibTeX |
EndNote:
XML,
Text |
RIS
Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters.
World journal of urology 42(1), 530 (2024) [10.1007/s00345-024-05232-6]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood.
npj precision oncology 8(1), 191 (2024) [10.1038/s41698-024-00689-5]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance.
Blood cancer journal 14(1), 148 (2024) [10.1038/s41408-024-01126-3]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma.
Acta neuropathologica 148(1), 17 (2024) [10.1007/s00401-024-02777-z]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Gender-specific differences in bariatric surgery: epidemiology, treatment and results. |[Geschlechtsspezifische Unterschiede in der Adipositaschirurgie: Epidemiologie, Therapie und Ergebnisse].
Die Chirurgie 95(9), 721?729 (2024) [10.1007/s00104-024-02149-z]
BibTeX |
EndNote:
XML,
Text |
RIS
How do deep-learning models generalize across populations? Cross-ethnicity generalization of COPD detection.
Insights into imaging 15(1), 198 (2024) [10.1186/s13244-024-01781-x]
BibTeX |
EndNote:
XML,
Text |
RIS
Clinical Presentation, Management, and Outcome in Neurolymphomatosis: A Systematic Review.
Neurology 103(4), e209698 (2024) [10.1212/WNL.0000000000209698]
BibTeX |
EndNote:
XML,
Text |
RIS
Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CT .[Erkennung myelomassoziierter osteolytischer Knochenläsionen mit energieintegrierender und photonenzählender Detektor-Computertomographie].
Die Radiologie 64(Suppl 1), 24-31 (2024) [10.1007/s00117-024-01344-7]
BibTeX |
EndNote:
XML,
Text |
RIS
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).
HemaSphere 8(7), e123 (2024) [10.1002/hem3.123]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation.
JCO precision oncology 8(8), e2300613 (2024) [10.1200/PO.23.00613]
BibTeX |
EndNote:
XML,
Text |
RIS
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications - a HARMONY study.
Leukemia 38(9), 1929-1937 (2024) [10.1038/s41375-024-02333-4]
BibTeX |
EndNote:
XML,
Text |
RIS
Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms.
European radiology 34, 7909?7920 (2024) [10.1007/s00330-024-10818-0]
BibTeX |
EndNote:
XML,
Text |
RIS
The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/?-thalassaemia and no or low HbA expression.
European journal of haematology 113(4), 501-509 (2024) [10.1111/ejh.14259]
BibTeX |
EndNote:
XML,
Text |
RIS
Interaction Difference Hypothesis Test for Prediction Models
Machine learning and knowledge extraction 6(2), 1298 - 1322 (2024) [10.3390/make6020061]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.
British journal of cancer 131(4), 763-777 (2024) [10.1038/s41416-024-02740-5]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income Countries.
International journal of molecular sciences 25(12), 6431 (2024) [10.3390/ijms25126431]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosis.
EBioMedicine 105, 105223 (2024) [10.1016/j.ebiom.2024.105223]
BibTeX |
EndNote:
XML,
Text |
RIS
CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.
Leukemia 38(7), 1621-1625 (2024) [10.1038/s41375-024-02290-y]
BibTeX |
EndNote:
XML,
Text |
RIS
Simulation study to evaluate when Plasmode simulation is superior to parametric simulation in estimating the mean squared error of the least squares estimator in linear regression.
PLOS ONE 19(5), e0299989 - (2024) [10.1371/journal.pone.0299989]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
European urology nn, nn (2024) [10.1016/j.eururo.2024.04.030]
BibTeX |
EndNote:
XML,
Text |
RIS
Reproducible Radiomics Features from Multi-MRI-Scanner Test-Retest-Study: Influence on Performance and Generalizability of Models.
Journal of magnetic resonance imaging nn, nn (2024) [10.1002/jmri.29442]
BibTeX |
EndNote:
XML,
Text |
RIS
Low tumor interleukin-1? expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study.
Pulmonology nn, nn (2024) [10.1016/j.pulmoe.2024.03.003]
BibTeX |
EndNote:
XML,
Text |
RIS
Addition of inflammation-related biomarkers to the CAIDE model for risk prediction of all-cause dementia, Alzheimer's disease and vascular dementia in a prospective study.
Immunity & ageing 21(1), 23 (2024) [10.1186/s12979-024-00427-2]
BibTeX |
EndNote:
XML,
Text |
RIS
Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause.
Transplantation and cellular therapy 30(6), 586.e1-586.e11 (2024) [10.1016/j.jtct.2024.03.017]
BibTeX |
EndNote:
XML,
Text |
RIS
Capturing COPD heterogeneity: anomaly detection and parametric response mapping comparison for phenotyping on chest computed tomography.
Frontiers in medicine 11, 1360706 (2024) [10.3389/fmed.2024.1360706]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis.
Frontiers in Public Health 12, 1307427 (2024) [10.3389/fpubh.2024.1307427]
Files Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma.
European journal of nuclear medicine and molecular imaging 51(8), 2293-2307 (2024) [10.1007/s00259-024-06668-z]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Cytomegalovirus immunoglobulin serology prevalence in patients with newly diagnosed multiple myeloma treated within the GMMG-MM5 phase III trial.
Hematology 29(1), 2320006 (2024) [10.1080/16078454.2024.2320006]
BibTeX |
EndNote:
XML,
Text |
RIS
Statistical plasmode simulations-Potentials, challenges and recommendations.
Statistics in medicine 43(9), 1804-1825 (2024) [10.1002/sim.10012]
BibTeX |
EndNote:
XML,
Text |
RIS
Understanding metric-related pitfalls in image analysis validation.
Nature methods 21(2), 182 - 194 (2024) [10.1038/s41592-023-02150-0]
BibTeX |
EndNote:
XML,
Text |
RIS
Metrics reloaded: recommendations for image analysis validation.
Nature methods 21(2), 195 - 212 (2024) [10.1038/s41592-023-02151-z]
BibTeX |
EndNote:
XML,
Text |
RIS
A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS II.
Statistical methods in medical research 33(3), 433-448 (2024) [10.1177/09622802241227951]
BibTeX |
EndNote:
XML,
Text |
RIS
Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
Acta dermato-venereologica 104, adv13381 - (2024) [10.2340/actadv.v104.13381]
BibTeX |
EndNote:
XML,
Text |
RIS
Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6): results from a randomised, phase 3 trial.
The lancet / Haematology 11(2), e101 - e113 (2024) [10.1016/S2352-3026(23)00366-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts.
Leukemia 38(2), 389-392 (2024) [10.1038/s41375-024-02143-8]
BibTeX |
EndNote:
XML,
Text |
RIS
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
Journal for ImmunoTherapy of Cancer 12(1), e007635 (2024) [10.1136/jitc-2023-007635]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.
Clinical chemistry 70(1), 297 - 306 (2024) [10.1093/clinchem/hvad180]
BibTeX |
EndNote:
XML,
Text |
RIS
Prediction of disease severity in COPD: a deep learning approach for anomaly-based quantitative assessment of chest CT.
European radiology 34(7), 4379-4392 (2024) [10.1007/s00330-023-10540-3]
BibTeX |
EndNote:
XML,
Text |
RIS
Robust incorporation of historical information with known type I error rate inflation.
Biometrical journal 66(1), e2200322 (2024) [10.1002/bimj.202200322]
BibTeX |
EndNote:
XML,
Text |
RIS
Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients.
Leukemia 38(3), 640-647 (2024) [10.1038/s41375-023-02105-6]
BibTeX |
EndNote:
XML,
Text |
RIS
Onset time and characteristics of post-procedural bleeding after endoscopic resection of colorectal lesions: a multicenter retrospective study.
Digestive diseases 42(1), 78-86 (2024) [10.1159/000534109]
BibTeX |
EndNote:
XML,
Text |
RIS
CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: a systematic review and external validation study.
Critical reviews in oncology, hematology 193, 104199 (2024) [10.1016/j.critrevonc.2023.104199]
BibTeX |
EndNote:
XML,
Text |
RIS
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
European urology 85(2), 105-111 (2024) [10.1016/j.eururo.2023.09.027]
BibTeX |
EndNote:
XML,
Text |
RIS
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
Journal of clinical oncology 42(1), 26-37 (2024) [10.1200/JCO.23.01696]
BibTeX |
EndNote:
XML,
Text |
RIS
Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
Pharmaceutical statistics 23(1), 4-19 (2024) [10.1002/pst.2334]
BibTeX |
EndNote:
XML,
Text |
RIS
Weakly Supervised MRI Slice-Level Deep Learning Classification of Prostate Cancer Approximates Full Voxel- and Slice-Level Annotation: Effect of Increasing Training Set Size.
Journal of magnetic resonance imaging 59(4), 1409-1422 (2024) [10.1002/jmri.28891]
BibTeX |
EndNote:
XML,
Text |
RIS
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Haematologica 109(1), 72-83 (2024) [10.3324/haematol.2023.282912]
BibTeX |
EndNote:
XML,
Text |
RIS
Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
Statistics in biopharmaceutical research 16(2), 141-157 (2024) [10.1080/19466315.2023.2211023]
BibTeX |
EndNote:
XML,
Text |
RIS
Bovine meat and milk factor protein expression in tumor-free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival.
Molecular oncology 18(5), 1076-1092 (2024) [10.1002/1878-0261.13390]
BibTeX |
EndNote:
XML,
Text |
RIS